Orrick advised Twist Bioscience on its $70 million initial public offering of 5,000,000 shares of common stock. The offering priced at $14 per share and began…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now